These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 19775830
1. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule. Wallace M, Martinez A, Mitchell C, Chen PY, Ghilezan M, Benitez P, Brown E, Vicini F. Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):531-6. PubMed ID: 19775830 [Abstract] [Full Text] [Related]
2. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, White J, Hedberg P, Hebert M, Arthur D, Zannis V, Quiet C, Streeter O, Silverstein M. Am J Surg; 2007 Oct 01; 194(4):456-62. PubMed ID: 17826055 [Abstract] [Full Text] [Related]
3. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R. Am J Surg; 2006 Oct 01; 192(4):427-33. PubMed ID: 16978943 [Abstract] [Full Text] [Related]
4. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A. Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):32-40. PubMed ID: 17467920 [Abstract] [Full Text] [Related]
5. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Chen PY, Vicini FA, Benitez P, Kestin LL, Wallace M, Mitchell C, Pettinga J, Martinez AA. Cancer; 2006 Mar 01; 106(5):991-9. PubMed ID: 16421922 [Abstract] [Full Text] [Related]
6. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer H, Whitacre EB, Whitworth PW, Fine RE, Haffty BG, Arrambide LS. Cancer; 2005 Sep 15; 104(6):1138-48. PubMed ID: 16088962 [Abstract] [Full Text] [Related]
10. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy. Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A. Am J Surg; 2004 Oct 01; 188(4):355-64. PubMed ID: 15474426 [Abstract] [Full Text] [Related]
11. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, Haffty BG. Ann Surg Oncol; 2009 Sep 01; 16(9):2450-8. PubMed ID: 19517191 [Abstract] [Full Text] [Related]
12. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Vicini FA, Chen P, Wallace M, Mitchell C, Hasan Y, Grills I, Kestin L, Schell S, Goldstein NS, Kunzman J, Gilbert S, Martinez A. Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1124-30. PubMed ID: 17967306 [Abstract] [Full Text] [Related]
17. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Kaufman SA, DiPetrillo TA, Price LL, Midle JB, Wazer DE. Brachytherapy; 2007 Jan 01; 6(4):286-92. PubMed ID: 17991625 [Abstract] [Full Text] [Related]
18. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, Bernik S, Scarpinato V, Mills C. Ann Surg Oncol; 2004 Aug 01; 11(8):739-46. PubMed ID: 15249336 [Abstract] [Full Text] [Related]
19. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Niehoff P, Ballardini B, Polgár C, Major T, Hammer J, Richetti A, Kovács G. Breast; 2006 Jun 01; 15(3):319-25. PubMed ID: 16765284 [Abstract] [Full Text] [Related]
20. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Vicini FA, Keisch M, Shah C, Goyal S, Khan AJ, Beitsch PD, Lyden M, Haffty BG. Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):512-8. PubMed ID: 22079730 [Abstract] [Full Text] [Related] Page: [Next] [New Search]